New heart valve fix without surgery: 20-Patient trial begins
NCT ID NCT07244939
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new device called the Cephea Mitral Valve System for people with mitral valve disease (leaky or narrowed heart valves) who cannot have open-heart surgery. The goal is to see if the device is safe and works well. About 20 people will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Clinico San Borja Arriarán
RECRUITINGSantiago, 8360160, Chile
-
Instituto Nacional del Torax
RECRUITINGSantiago, 8320000, Chile
-
Instituto do Coracao (InCor) - HCFMUSP
RECRUITINGSão Paulo, 05403-900, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI ultrasound could unmask silent heart disease in seniors
- Can a new valve device fix a leaky heart without open surgery?
- Can mixed reality make heart valve surgery safer and faster?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- New heart valve device could spare High-Risk patients from Open-Heart surgery
- First-in-Human trial aims to offer new hope for patients with leaky heart valves who Can't have surgery